Gilead Sciences (GILD) Retained Earnings (2009 - 2026)

Gilead Sciences (GILD) has reported Retained Earnings for 18 consecutive years, with $9.5 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Retained Earnings fell 15.83% year-over-year to $9.5 billion; the trailing twelve-month figure through Jun 2026 stood at $9.5 billion (down 15.83% YoY), and the FY2025 full-year result was $13.7 billion, up 19.42% from the prior year.
• Retained Earnings declined to $9.5 billion in Q2 2026 per GILD's latest filing, from $14.1 billion in the prior quarter.
• Across five years, Retained Earnings topped out at $16.3 billion in Q4 2023 and bottomed at $9.5 billion in Q2 2026.
• Historically, Retained Earnings has averaged $13.4 billion across 5 years, with a median of $13.9 billion in 2025.
• The sharpest annual moves came in 2024 and 2026: Retained Earnings sank 30.8% in 2024, then gained 29.27% in 2026.
• Over 5 years, Retained Earnings stood at $15.7 billion in 2022, then increased by 3.93% to $16.3 billion in 2023, then slipped by 29.48% to $11.5 billion in 2024, then grew by 19.42% to $13.7 billion in 2025, then sank by 30.58% to $9.5 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $9.5 billion, $14.1 billion, and $13.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.